Synopsis
Synopsis
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Antergan
2. Cyproheptadine
3. Dihexazin
4. Periactin
5. Peritol
6. Viternum
1. 969-33-5
2. Cyproheptadine Hcl
3. Periactin Hydrochloride
4. Anarexol
5. Cipractin
6. Nuran
7. Antegan
8. Peritol
9. Periactin Syrup
10. Component Of Dronactin
11. Cyproheptadine (hydrochloride)
12. Cyproheptadine Hydrochloride Anhydrous
13. Cyproheptadiene Hydrochloride
14. 41354-29-4
15. Nsc-169911
16. Cyproheptadine Hydrochloride Sesquihydrate
17. Cyproheptadine Hydrochloride (anhydrous)
18. Cpd000058431
19. Mls000028462
20. Chebi:59695
21. 0s9323mct0
22. 4-(5h-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine Hydrochloride
23. Periactine
24. Nsc-759282
25. Smr000058431
26. 4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine Hydrochloride
27. Cyproheptadine (hydrochloride Sesquihydrate)
28. 1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine Hydrochloride
29. 1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine;hydrochloride
30. Periactinol (van)
31. Contrallerg
32. Kulinet
33. Kyliver
34. Sialotin
35. Vinorex
36. Istam
37. Periactinol Hydrochloride
38. Cyproheptadine Chlorhydrate
39. 4-(5h-dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine Hydrochloride
40. 4-(5h-dibenzo[a,d]cyclohepten-5-ylidine)-methylpiperidine Hydrochloride
41. Cycloheptadine Hydrochloride
42. Cyproheptadine Hydrochloride Hydrate
43. Vufb3511
44. Sr-01000003077
45. Einecs 213-535-1
46. Nsc 169911
47. C21h21n.hcl
48. Unii-0s9323mct0
49. 4-(5-dibenzo[a,e]cycloheptatrienylidene)piperidine Hydrochloride
50. Ai3-26940
51. 1-methyl-4-(5-dibenzo[a,e]cycloheptatrienylidene)piperidine Hydrochloride
52. 4-(dibenzo[2,1-b:1',2'-e][7]annulen-11-ylidene)-1-methylpiperidine;hydrochloride
53. Cycloheptadine Hcl
54. Prestwick_139
55. Opera_id_383
56. Cypoheptadine Hydrochloride
57. Cyproheptadine-hydrochloride
58. Piperidine, 4-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-1-methyl-, Hydrochloride
59. Chembl1716
60. Schembl41842
61. Mls001077277
62. Mls001424281
63. Mls002222173
64. Regid_for_cid_13770
65. Cyproptadine Hydrochloride,(s)
66. Dtxsid5042586
67. Hy-b0366a
68. Hms1568e08
69. Hms3414j05
70. Hms3678j03
71. Pharmakon1600-01505973
72. Bcp34399
73. Cyproheptadine Hydrochloride (anh.)
74. Tox21_500246
75. Anhydrous Cyproheptadine Hydrochloride
76. Mfcd00012538
77. Nsc169911
78. Nsc759282
79. S2044
80. Akos015905305
81. Ccg-101144
82. Lp00246
83. Nc00394
84. Cyproheptadine Hydrochloride (periactin)
85. Ncgc00093708-01
86. Ncgc00093708-02
87. Ncgc00260931-01
88. Ac-15790
89. As-14697
90. Cyproheptadine Hydrochloride [who-dd]
91. Eu-0100246
92. Ft-0603147
93. Sw196450-4
94. C 6022
95. C77331
96. Wln: L C676 Byj Bu- Dt6n Dytj A1 &gh
97. Sr-01000003077-2
98. Sr-01000003077-4
99. Sr-01000003077-9
100. W-106308
101. Cyproheptadine Hydrochloride 100 Microg/ml In Methanol
102. Q27126856
103. Piperidine,d]cyclohepten-5-ylidene)-1-methyl-, Hydrochloride
104. 4-(5h-dibenzo [a,d]cyclohepten-5-ylidene)-1-methylpiperidine Hydrochloride
105. 4-(5h-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidinehydrochloride
106. 4-(5h-dibenzo[a,d]cyclohepten-5-yli Dine)-methylpiperidine Hydrochloride
107. 1-methyl-4-(2-tricyclo[9.4.0.0^{3,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine;hydrochloride
108. 1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine Hydrochloride
| Molecular Weight | 323.9 g/mol |
|---|---|
| Molecular Formula | C21H22ClN |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 323.1440774 g/mol |
| Monoisotopic Mass | 323.1440774 g/mol |
| Topological Polar Surface Area | 3.2 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 423 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Cyproheptadine hydrochloride |
| PubMed Health | Cyproheptadine Hydrochloride (By mouth) |
| Drug Classes | Respiratory Agent |
| Drug Label | Cyproheptadine HCl USP, is an antihistaminic and antiserotonergic agent.Cyproheptadine hydrochloride USP is a white to slightly yellowish crystalline solid, with a molecular weight of 350.89, which is soluble in water, freely soluble in methanol, spa... |
| Active Ingredient | Cyproheptadine hydrochloride |
| Dosage Form | Tablet; Syrup |
| Route | Oral |
| Strength | 4mg; 2mg/5ml |
| Market Status | Prescription |
| Company | Lyne; Corepharma; Stason Pharms; Ivax Sub Teva Pharms; Pharm Assoc; Par Pharm |
| 2 of 2 | |
|---|---|
| Drug Name | Cyproheptadine hydrochloride |
| PubMed Health | Cyproheptadine Hydrochloride (By mouth) |
| Drug Classes | Respiratory Agent |
| Drug Label | Cyproheptadine HCl USP, is an antihistaminic and antiserotonergic agent.Cyproheptadine hydrochloride USP is a white to slightly yellowish crystalline solid, with a molecular weight of 350.89, which is soluble in water, freely soluble in methanol, spa... |
| Active Ingredient | Cyproheptadine hydrochloride |
| Dosage Form | Tablet; Syrup |
| Route | Oral |
| Strength | 4mg; 2mg/5ml |
| Market Status | Prescription |
| Company | Lyne; Corepharma; Stason Pharms; Ivax Sub Teva Pharms; Pharm Assoc; Par Pharm |
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
Antipruritics
Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Bioplus Life Sciences
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Disintegrants & Superdisintegrants
Direct Compression
Thickeners and Stabilizers
Lubricants & Glidants
Granulation
Co-Processed Excipients
Taste Masking
Controlled & Modified Release
Chewable & Orodispersible Aids
Coating Systems & Additives
Parenteral
Film Formers & Plasticizers
Topical
Emulsifying Agents
Solubilizers
Rheology Modifiers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
87
PharmaCompass offers a list of Cyproheptadine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cyproheptadine Hydrochloride manufacturer or Cyproheptadine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cyproheptadine Hydrochloride manufacturer or Cyproheptadine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Cyproheptadine Hydrochloride API Price utilized in the formulation of products. Cyproheptadine Hydrochloride API Price is not always fixed or binding as the Cyproheptadine Hydrochloride Price is obtained through a variety of data sources. The Cyproheptadine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Viternum manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Viternum, including repackagers and relabelers. The FDA regulates Viternum manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Viternum API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Viternum manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Viternum supplier is an individual or a company that provides Viternum active pharmaceutical ingredient (API) or Viternum finished formulations upon request. The Viternum suppliers may include Viternum API manufacturers, exporters, distributors and traders.
click here to find a list of Viternum suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Viternum DMF (Drug Master File) is a document detailing the whole manufacturing process of Viternum active pharmaceutical ingredient (API) in detail. Different forms of Viternum DMFs exist exist since differing nations have different regulations, such as Viternum USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Viternum DMF submitted to regulatory agencies in the US is known as a USDMF. Viternum USDMF includes data on Viternum's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Viternum USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Viternum suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Viternum Drug Master File in Japan (Viternum JDMF) empowers Viternum API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Viternum JDMF during the approval evaluation for pharmaceutical products. At the time of Viternum JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Viternum suppliers with JDMF on PharmaCompass.
A Viternum CEP of the European Pharmacopoeia monograph is often referred to as a Viternum Certificate of Suitability (COS). The purpose of a Viternum CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Viternum EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Viternum to their clients by showing that a Viternum CEP has been issued for it. The manufacturer submits a Viternum CEP (COS) as part of the market authorization procedure, and it takes on the role of a Viternum CEP holder for the record. Additionally, the data presented in the Viternum CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Viternum DMF.
A Viternum CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Viternum CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Viternum suppliers with CEP (COS) on PharmaCompass.
A Viternum written confirmation (Viternum WC) is an official document issued by a regulatory agency to a Viternum manufacturer, verifying that the manufacturing facility of a Viternum active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Viternum APIs or Viternum finished pharmaceutical products to another nation, regulatory agencies frequently require a Viternum WC (written confirmation) as part of the regulatory process.
click here to find a list of Viternum suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Viternum as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Viternum API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Viternum as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Viternum and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Viternum NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Viternum suppliers with NDC on PharmaCompass.
Viternum Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Viternum GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Viternum GMP manufacturer or Viternum GMP API supplier for your needs.
A Viternum CoA (Certificate of Analysis) is a formal document that attests to Viternum's compliance with Viternum specifications and serves as a tool for batch-level quality control.
Viternum CoA mostly includes findings from lab analyses of a specific batch. For each Viternum CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Viternum may be tested according to a variety of international standards, such as European Pharmacopoeia (Viternum EP), Viternum JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Viternum USP).
